Arkolith/Insider Trading/BLTE/Form 4

Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Apr 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$166K
Net Open-Market Flow
-$166K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 23, 2026Sell(S)267$164.47$44K10K
Apr 23, 2026Sell(S)158$165.38$26K10K
Apr 23, 2026Sell(S)127$166.56$21K10K
Apr 23, 2026Sell(S)373$167.37$62K10K
Apr 23, 2026Sell(S)54$168.43$9K10K
Apr 23, 2026Sell(S)21$169.56$4K10K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-177293) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML